Enclosed herewith is the Annual Secretarial Compliance Report
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Supriya Lifescience has filed its Annual Secretarial Compliance Report for the year ended March 31, 2026, as required under SEBI Regulation 24A. The report, issued by Practicing Company Secretary M/s. DSM & Associates, confirms that the company maintained full compliance with all applicable SEBI regulations throughout the review period. The examination covered regulations including SEBI LODR, ICDR, SAST, PIT, and other relevant guidelines. All 13 compliance checkpoints in the report show 'Yes' or 'Not Applicable' status with no deviations, violations, or penalties reported. No actions were taken by SEBI or stock exchanges against the company, its promoters, or directors during the period.
This clean compliance report is a positive indicator of the company's governance standards and regulatory adherence. For shareholders, this confirms that the company has maintained proper disclosures, documentation, and compliance practices as mandated by SEBI for listed entities.